Nephrolytics, Inc., a clinical intelligence platform driven by AI, is transforming kidney treatment and is emerging as a leader in specialized healthcare AI innovation. With plans for an upcoming bridge round this September and the successful completion of a $2.5M SAFE funding round, the company is using innovative technology to transform healthcare delivery by addressing workforce shortages, physician burnout, and the pressing shift to value-based care. Nephrolytics pioneers the first full-stack agentic AI solution specifically designed for nephrology, moving the industry from legacy EMR systems to next-generation clinical intelligence platforms. Founded by Fahim Rahim, MD, MBA, a distinguished nephrologist...
BlockchainFebruary 13, 2026February 13, 2026

